Strattera Product Description
Strattera is a CNS stimulant used to control over various types of behavioral disorder in patients diagnosed with attention deficit hyperactivity disorder (ADHD). Strattera is often used when other CNS stimulants are not effective or contraindicated. Strattera has no structural resemblance to other ADHD agents and provides a mild, but effective therapeutic effect.
Strattera can be indicated for adults and children over 6 years. Strattera is often indicated to pediatric patients because no withdrawal syndrome associated adverse reactions are not observed after the course of treatment with ADHD.
In the first week, 40mg of Strattera should be taken as a single dose or divided in two parts a day. After evaluation of response, dosage may be gradually increased to a maximum dose of Strattera 100mg per day. The dosage for children is indicated, depending on their body weight.
Missed dose of Strattera should be taken as soon as possible. However, do not take a double assigned dosage of norepinephrine reuptake inhibitor Strattera.
Strattera is not an amphetamine derivative; however, duration of the drug application should be limited. The necessity of Strattera application should be reevaluated at least every 12 months or after the satisfactory response.
Recommended conditions for storage of Strattera: cool, dry place at controlled room temperature not exceeding 30°C.
Strattera Safety Information
The patients with existing or pre-existing partial loss of heart function should take the lowest effective dose of Strattera. Most patients taking Strattera capsules observe a slight increase in blood pressure that does not require the dosing regimen to be adjusted.
All information about attention deficit disorder treatment, contained in the review of Strattera, is intended for informational purposes only. This information should not be used as a replacement of professional medical advice of the pediatrician, psychologist or other health care professional. The online pharmacy provides the information without any representations or warranties that it will be used without any damages.
Strattera Side Effects
Strattera is confirmed to be a drug with a low incidence of serious adverse events. ADHD treatment is reported to be stopped in about 3% of children and adolescents taking Strattera due to: nausea, vomiting, irritability, fatigue, decreased appetite, indigestion, headache, abdominal pain, increased blood pressure, somnolence or rhinorrhoea. In adult patients with ADHD, Strattera may cause dry mouth, insomnia, increased heart rate, palpitations, rash, dyspepsia, decreased libido, muscle pain, blurred vision, shivering, and hot flushes.